Rhenovia Pharma
Mulhouse · Founded 2007
About Rhenovia Pharma
Rhenovia Pharma SAS is a French biotechnology company founded in 2007 by an international team that brings together managers from large pharmaceutical companies and world experts in neuroscience and nervous system modeling. The company is the world leader in the application of biosimulation in the prevention and treatment of neurological, neurodegenerative and psychiatric disorders and diseases. Based in Mulhouse (France) and Cambridge (Massachusetts), Rhenovia has around twenty members of staff in France, Switzerland, Germany and the US.
Company Facts
- Founded: 2007
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2014)
- Website: http://rhenovia.com
- Phone: 33 3 89 32 76 84
Industries & Categories
Biotechnology, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/rhenovia-pharma-2624759 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.